Healthcare
M&A Advisory
Pharmaceutical
Research
M&A Advisory
Lazard
Full Credential Description
Gilead Sciences. Belgium, United States. Announced Date 14/07/2019. Closed Date 23/08/2019. Deal value: $5100m. Gilead and Galapagos enter into research and development collaboration. Industry: Gilead Sciences is a biopharmaceutical company that focuses on the research, development, and commercialization of antiviral drugs and treatments.